Niedobór dehydrogenazy acyl-coa o łańcuchu średnim
Leczenie
Niedobór dehydrogenazy acyl-CoA o łańcuchu średnim (MCAD) to dziedziczne zaburzenie metaboliczne uniemożliwiające prawidłowy rozkład średniołańcuchowych kwasów tłuszczowych, co prowadzi do ryzyka hipoglikemii i kryzysów metabolicznych. Diagnostyka opiera się na badaniach przesiewowych noworodków, a leczenie koncentruje się na zapobieganiu długotrwałemu głodzeniu oraz utrzymaniu prawidłowego poziomu glukozy we krwi. Zalecenia dietetyczne obejmują ograniczenie tłuszczów do <30% dziennej podaży kalorii, zwiększenie węglowodanów złożonych oraz unikanie MCT. W stanach chorobowych i zwiększonego wysiłku fizycznego konieczne jest zwiększenie podaży węglowodanów. W przypadku niemowląt maksymalne bezpieczne okresy głodzenia wynoszą 4-5 godzin (<6 m-cy), 8 godzin (6-12 m-cy) i 10 godzin (12-24 m-cy). W kryzysie metabolicznym stosuje się dożylne podawanie glukozy 10% (bolus 25% glukozy 2 ml/kg przy hipoglikemii) oraz leczenie kwasicy metabolicznej wodorowęglanem sodu (1 mEq/kg). Monitorowanie glikemii powinno utrzymywać poziomy 5-9 mmol/l (120-170 mg/dl).
- Leczenie niedoboru dehydrogenazy acyl-coa o łańcuchu średnim
- Postępowanie dietetyczne
- Suplementacja L-karnityną
- Postępowanie w czasie choroby
- Postępowanie w sytuacjach szczególnych
- Przygotowanie do zabiegów chirurgicznych
- Postępowanie przy zwiększonej aktywności fizycznej
- Ciąża i niedobór MCAD
- Nowe podejścia terapeutyczne
- Plan postępowania awaryjnego
- Monitorowanie i długoterminowa opieka
- Rokowanie
Leczenie niedoboru dehydrogenazy acyl-coa o łańcuchu średnim
Niedobór dehydrogenazy acyl-coa o łańcuchu średnim (MCAD) jest dziedzicznym zaburzeniem metabolicznym, w którym organizm nie jest w stanie prawidłowo rozkładać średniołańcuchowych kwasów tłuszczowych na energię. Chociaż nie istnieje definitywne leczenie przyczynowe tego schorzenia, wczesna diagnoza (zwłaszcza poprzez badania przesiewowe noworodków) i odpowiednie postępowanie terapeutyczne mogą znacząco poprawić rokowanie i pozwolić pacjentom prowadzić normalne życie.123
Główne cele leczenia
Podstawowym celem leczenia niedoboru MCAD jest zapobieganie problemom metabolicznym, które mogą prowadzić do hipoglikemii. Postępowanie terapeutyczne koncentruje się na utrzymaniu prawidłowego poziomu glukozy we krwi poprzez odpowiednie postępowanie dietetyczne i zapobieganie długim okresom głodzenia.123
Kluczowe elementy leczenia obejmują:12
- Unikanie długotrwałego głodzenia
- Zapewnienie odpowiedniej podaży węglowodanów w diecie
- Ograniczenie spożycia tłuszczów
- Wdrożenie specjalnego protokołu postępowania w przypadku choroby lub zwiększonego wysiłku fizycznego
- Przygotowanie planu postępowania w sytuacjach nagłych
Zespół terapeutyczny
Leczenie niedoboru MCAD wymaga współpracy interdyscyplinarnego zespołu specjalistów, w skład którego wchodzą:12
- Specjalista chorób metabolicznych
- Dietetyk kliniczny
- Pediatra
- Lekarz pierwszego kontaktu
Zespół ten opracowuje indywidualny plan leczenia dostosowany do potrzeb energetycznych pacjenta, uwzględniający dodatkowe zapotrzebowanie na węglowodany złożone w czasie choroby, stresu lub zwiększonej aktywności fizycznej.12
Postępowanie dietetyczne
Zasady ogólne
Dieta stanowi podstawę leczenia niedoboru MCAD. Choć pacjenci mogą tolerować normalną dietę, zaleca się wprowadzenie pewnych modyfikacji żywieniowych:12
- Ograniczenie tłuszczów w diecie do poziomu <30% dziennej podaży kalorii
- Zwiększenie podaży węglowodanów złożonych (pełnoziarniste pieczywo, ryż, makaron, płatki zbożowe)
- Unikanie produktów zawierających średniołańcuchowe trójglicerydy (MCT)
- Regularne spożywanie posiłków według ustalonego harmonogramu
Karmienie niemowląt
W przypadku niemowląt z niedoborem MCAD zaleca się:12
- Regularne karmienie, aby zapobiec długim okresom głodzenia
- Możliwość kontynuacji karmienia piersią lub stosowania standardowego mleka modyfikowanego
- Unikanie mieszanek zawierających średniołańcuchowe trójglicerydy (MCT)
- Zapewnienie odpowiedniej ilości kalorii pochodzących z węglowodanów złożonych
Częstotliwość karmienia niemowląt z niedoborem MCAD powinna być dostosowana do wieku dziecka, przy czym najważniejsze jest przestrzeganie maksymalnych bezpiecznych okresów głodzenia:12
- Niemowlęta <6 miesięcy: nie dłużej niż 4-5 godzin bez pokarmu
- Niemowlęta 6-12 miesięcy: nie dłużej niż 8 godzin bez pokarmu
- Dzieci 12-24 miesięcy: nie dłużej niż 10 godzin bez pokarmu
Żywienie dzieci i dorosłych
Dzieci starsze i dorośli z niedoborem MCAD powinni przestrzegać następujących zasad żywieniowych:12
- Regularne spożywanie posiłków i przekąsek zawierających odpowiednią ilość kalorii z węglowodanów złożonych
- Wybieranie produktów bogatych w węglowodany złożone i z niską zawartością tłuszczu
- Unikanie głodzenia dłuższego niż 12 godzin
- Zwiększenie spożycia węglowodanów złożonych podczas choroby, stresu lub zwiększonej aktywności fizycznej
- Ograniczenie spożycia alkoholu
Stosowanie skrobi kukurydzianej
W niektórych ośrodkach zaleca się podawanie surowej skrobi kukurydzianej przed snem, aby zapewnić powolne uwalnianie glukozy w nocy i zapobiec nocnej hipoglikemii:123
- Typowa dawka wynosi około 2 g/kg masy ciała
- Skrobia kukurydziana może być podawana w płynie
- Szczególnie przydatna u dzieci starszych i młodzieży
Suplementacja L-karnityną
Stosowanie suplementacji L-karnityną w leczeniu niedoboru MCAD pozostaje kwestią kontrowersyjną, a dowody na jej skuteczność są ograniczone i głównie anegdotyczne.123
Teoretyczne uzasadnienie stosowania L-karnityny:12
- Leczenie wtórnego niedoboru karnityny wynikającego z akumulacji acylokarnityn
- Ułatwienie sprzęgania i wydalania toksycznych metabolitów pośrednich
- Wspomaganie przemian metabolicznych kwasów tłuszczowych
Niektórzy specjaliści zalecają suplementację L-karnityną w dawce 50-100 mg/kg/dobę, jednak badania kliniczne nie wykazały jednoznacznie korzyści z takiego postępowania.12 Niektóre badania sugerują nawet, że suplementacja karnityną może pogorszyć stan kliniczny poprzez generowanie toksycznych długołańcuchowych pochodnych karnityny.1
Aktualnie suplementacja L-karnityną jest stosowana głównie w następujących sytuacjach:12
- U pacjentów z potwierdzonym niskim poziomem karnityny we krwi
- Krótkoterminowo podczas ostrej choroby (dawka dożylna 100 mg/kg masy ciała)
- W okresach zwiększonego katabolizmu
Postępowanie w czasie choroby
Zasady ogólne postępowania
Okres choroby jest szczególnie niebezpieczny dla pacjentów z niedoborem MCAD, ponieważ zwiększony katabolizm i zmniejszone spożycie pokarmów mogą prowadzić do kryzysu metabolicznego.12
Podstawowe zasady postępowania w czasie choroby obejmują:12
- Natychmiastowe wdrożenie protokołu awaryjnego
- Zwiększenie podaży węglowodanów
- Unikanie głodzenia
- Regularne podawanie polimerów glukozy (specjalne napoje wysokoenergetyczne)
- Niska próg dla hospitalizacji
Postępowanie domowe
W przypadku łagodnych objawów choroby można zastosować leczenie domowe, jeśli pacjent jest w stanie przyjmować doustnie odpowiednią ilość płynów i węglowodanów:12
- Podawanie prostych węglowodanów, takich jak tabletki glukozy lub słodzone napoje (nie oznaczone jako „dietetyczne”)
- Stosowanie specjalnych polimerów glukozy przepisanych na receptę (Maxijul, Polycal, SOS)
- Zwiększenie częstotliwości posiłków i przekąsek
Wskazania do hospitalizacji
Natychmiastowa hospitalizacja jest konieczna w następujących sytuacjach:123
- Niemożność przyjmowania pokarmów doustnie
- Wymioty lub biegunka
- Objawy hipoglikemii (zaburzenia świadomości, dezorientacja, senność)
- Objawy kryzysu metabolicznego
- Niezdolność do utrzymania odpowiedniego nawodnienia
Leczenie szpitalne
W warunkach szpitalnych leczenie pacjenta z niedoborem MCAD w stanie kryzysu metabolicznego obejmuje:123
- Natychmiastowe podanie 10% roztworu glukozy dożylnie (nie stosować 5% glukozy, która jest niewystarczająca)
- W przypadku hipoglikemii – bolus 25% glukozy w dawce 2 ml/kg, a następnie ciągły wlew 10% glukozy z prędkością 1,5-krotnie większą niż podstawowe zapotrzebowanie, aby zapewnić 7-8 mg/kg/min glukozy
- Leczenie kwasicy metabolicznej (przy poziomie wodorowęglanów <16 mEq/L) dożylnym wodorowęglanem sodu (1 mEq/kg)
- Monitorowanie poziomów glukozy we krwi (utrzymanie w zakresie 5-9 mmol/L lub 120-170 mg/dl)
- Leczenie przyczyn wywołujących kryzys (infekcja, odwodnienie)
Po ustabilizowaniu stanu klinicznego, pacjent nie powinien być wypisany ze szpitala, dopóki nie będzie w stanie przyjmować wystarczającej ilości płynów i pokarmów doustnie, aby utrzymać normoglikemię.12
Postępowanie w sytuacjach szczególnych
Przygotowanie do zabiegów chirurgicznych
Zabiegi chirurgiczne wymagające głodzenia stanowią szczególne wyzwanie dla pacjentów z niedoborem MCAD.12
Zalecenia dotyczące postępowania w okresie okołooperacyjnym:12
- Możliwość podawania przejrzystych płynów do 4 godzin przed zabiegiem
- Rozpoczęcie dożylnego podawania glukozy przed zabiegiem
- Kontynuacja wlewu dożylnego glukozy w trakcie zabiegu i po nim, aż do momentu, gdy pacjent będzie w stanie przyjmować odpowiednią ilość pokarmów doustnie i utrzyma normoglikemię
Postępowanie przy zwiększonej aktywności fizycznej
Zwiększona aktywność fizyczna może wymagać dostosowania diety u pacjentów z niedoborem MCAD:12
- Zapewnienie odpowiedniej podaży węglowodanów przed, w trakcie i po intensywnym lub długotrwałym wysiłku
- Odpowiednie nawodnienie
- Unikanie długich okresów wysiłku bez uzupełniania węglowodanów
Ciąża i niedobór MCAD
Kobiety z niedoborem MCAD mogą zachodzić w ciążę, ale wymagają specjalnej opieki.1 Szczegółowe zalecenia powinny być omówione z zespołem specjalistów chorób metabolicznych i obejmować:1
- Zwiększone zapotrzebowanie na kalorie i węglowodany w czasie ciąży
- Zapobieganie długim okresom głodzenia
- Szczególna uwaga podczas porodu i w okresie poporodowym
- Plan postępowania w przypadku wystąpienia wymiotów ciążowych lub innych powikłań
Nowe podejścia terapeutyczne
Leki w badaniach klinicznych
Obecnie trwają badania nad nowymi metodami leczenia niedoboru MCAD:123
- Fenylomaślan – badania kliniczne wykazały, że fenylomaślan może działać jako substrat dla enzymu MCAD i potencjalnie wspomagać jego funkcję. Stosowany jest jako lek Ravicti (glicerol fenylomaślan) w dawkach rozpoczynających się od 2 g/m²/dobę, co stanowi około jedną piątą dawki stosowanej w innych zaburzeniach.12
- Zmiatacze azotu (nitrogen scavengers), np. glicerol fenylomaślan, są obecnie badane jako terapia wspomagająca dla pacjentów z niedoborem MCAD.1
- Bezafibrat – aktywator receptora aktywowanego przez proliferatory peroksysomów, który indukuje transkrypcję różnych enzymów zaangażowanych w mitochondrialne utlenianie kwasów tłuszczowych.1
- Resveratrol – naturalny związek o właściwościach przeciwutleniających i przeciwzapalnych, który może poprawiać metabolizm energetyczny mitochondriów.1
Terapia genowa i komórkowa
Terapia genowa i komórkowa stanowi obiecujące podejście do leczenia niedoboru MCAD w przyszłości:1
- Badacze z Children’s Hospital of Philadelphia (CHOP) są pionierami w opracowywaniu terapii genowych zatwierdzonych przez FDA do stosowania u dzieci
- Trwają badania nad nowymi metodami leczenia i potencjalnego wyleczenia zaburzeń genetycznych u dzieci
- Terapia genowa mogłaby potencjalnie przywrócić prawidłową funkcję enzymu MCAD
Badania nad chemicznymi chaperonami zdolnymi do stabilizacji białka MCAD z mutacją K304E również wykazują obiecujące rezultaty. Związki takie jak TMAO i glicerol znacząco zwiększają aktywność MCAD w komórkach.1
Plan postępowania awaryjnego
Protokół awaryjny
Każdy pacjent z niedoborem MCAD powinien posiadać protokół awaryjny (emergency protocol) przygotowany przez specjalistę chorób metabolicznych.12 Protokół ten powinien:12
- Być zawsze dostępny dla pacjenta lub jego opiekunów
- Zawierać jasne instrukcje dotyczące postępowania w sytuacjach nagłych
- Zawierać dane kontaktowe specjalistów
- Być przedstawiany personelowi medycznemu w przypadku konieczności leczenia
Identyfikacja medyczna
Pacjenci z niedoborem MCAD powinni nosić bransoletki lub naszyjniki medyczne oraz posiadać przy sobie kartę medyczną informującą o ich schorzeniu.1 Jest to szczególnie istotne w sytuacjach nagłych, gdy pacjent nie jest w stanie sam przekazać informacji o swojej chorobie.1
Monitorowanie i długoterminowa opieka
Regularne wizyty kontrolne
Pacjenci z niedoborem MCAD wymagają regularnych wizyt kontrolnych, które obejmują:12
- Ocenę wzrostu i rozwoju
- Monitorowanie kontroli metabolicznej
- Dostosowanie planu leczenia do zmieniających się potrzeb pacjenta
- Edukację pacjenta i rodziny
Edukacja pacjenta i rodziny
Zrozumienie przez pacjenta i rodzinę istoty choroby jest kluczowe dla długoterminowej opieki i zapobiegania powikłaniom.1 Edukacja powinna obejmować:12
- Zrozumienie znaczenia unikania głodzenia
- Umiejętność rozpoznawania objawów hipoglikemii i kryzysu metabolicznego
- Wiedzę na temat prawidłowego postępowania w przypadku choroby
- Świadomość konieczności długoterminowego przestrzegania zaleceń dietetycznych i leczenia
Rokowanie
Przy wczesnym rozpoznaniu i odpowiednim leczeniu, rokowanie dla pacjentów z niedoborem MCAD jest bardzo dobre:123
- Większość pacjentów może prowadzić normalne, zdrowe życie z prawidłowym wzrostem i rozwojem
- Oczekiwana długość życia jest normalna lub zbliżona do normalnej
- Ryzyko kryzysu metabolicznego zmniejsza się z wiekiem
- W przypadku nieleczonego niedoboru MCAD, ryzyko zgonu jest szacowane na około 20%
Należy podkreślić, że leczenie niedoboru MCAD jest leczeniem przewlekłym, wymagającym stałego przestrzegania zaleceń dietetycznych i innych elementów terapii.12 Długoterminowa współpraca z zespołem leczącym jest niezbędna do zapewnienia optymalnego stanu zdrowia pacjenta.1
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
MCAD deficiency is diagnosed through newborn screening followed by genetic testing. […] A metabolic specialist, and often a registered dietitian, are usually included in your diagnosis and treatment. Lab tests can be done to help identify problems with your metabolism the processes your body uses to produce energy. Results can help treat or prevent complications. […] Newborn screening at birth allows MCAD deficiency to be diagnosed and treated early, before symptoms occur, preventing complications. Once identified, the disorder can be managed through diet and lifestyle. […] The main goal of treatment for MCAD deficiency is to prevent problems caused by your metabolism that can lead to low blood sugar. To maintain blood sugar levels and avoid hypoglycemia: Infants require frequent feedings that include getting enough calories from complex carbohydrates. Children and adults need to get enough complex carbohydrates on a regular schedule of meals and snacks.
- #1 MCAD Deficiencyhttps://my.clevelandclinic.org/health/diseases/21973-mcad-deficiency
Treatment for MCAD deficiency focuses on meeting nutritional requirements for your child’s body and reducing long periods of time between meals, which may trigger symptoms of the condition. Dietary requirements for MCAD deficiency include: […] Scheduling meals more frequently throughout the day. […] Eating a diet high in carbohydrates. […] Avoiding excessive fat in your child’s diet (heart-healthy diet). […] Taking carnitine supplements to assist fat to energy conversion. […] For adults with MCAD deficiency, excessive alcohol consumption may cause severe symptoms (metabolic crisis). If this occurs, taking a glucose supplement or eating foods high in sugar helps manage the side effects of the condition. […] Symptoms of MCAD deficiency vary based on the severity of the diagnosis. Symptoms arise during long periods without eating. Scheduling meals more frequently throughout the day helps minimize symptoms of the condition. Eating complex carbohydrates like whole grains, some types of vegetables and beans before bedtime alleviates the need to wake up in the middle of the night to maintain steady glucose levels. […] Your healthcare provider might recommend meeting with a dietitian to monitor your child’s diet and exercise and to advise on healthy eating habits to alleviate symptoms of the condition.
- #1 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency – GeneReviews® – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK1424/
Management. Treatment of manifestations: For routine daily treatment, fasting should be avoided and may require frequent feeding (every 2-3 hours) in infancy, overnight feeding, a bedtime snack, or 2 g/kg of uncooked cornstarch to maintain blood glucose levels during sleep. A normal, healthy diet containing no more than 30% of total energy from fat is recommended. All individuals with MCAD deficiency should avoid skipping meals and weight loss diets that recommend fasting. Prolonged or intense exercise should be covered by adequate carbohydrate intake and hydration. Intravenous glucose is recommended for surgical procedures that require several hours of fasting. Weight control measures such as regular education about proper nutrition and recommended physical exercise should be discussed to help avoid obesity. Standard treatment for developmental delay / aphasia, attention-deficit/hyperactivity disorder, and muscle weakness. For acute inpatient treatment, IV administration of glucose should be initiated immediately with 10% dextrose with appropriate electrolytes at a rate of 1.5 times maintenance rate or at 10-12 mg glucose/kg/minute to achieve and maintain a blood glucose level higher than 5 mmol/L, or between 120 and 170 mg/dL. Address electrolyte and pH imbalances with intravenous fluid management and initiate appropriate treatment for what triggered the metabolic stress.
- #1 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
Your health care team may recommend additional treatment options. […] Work with your health care team, including a registered dietitian, to develop a treatment plan tailored to your energy needs. This includes planning for extra complex carbohydrates needed during illness, stress or increased activity. […] Recommendations to prevent low blood sugar called hypoglycemia generally include: Avoid fasting longer than recommended by your health care team. Eat regular meals and snacks with adequate calories from complex carbohydrates, such as brown bread, rice, pasta and cereal, for energy needs. Choose foods that are high in complex carbohydrates and lower in fat. Increase calories by eating extra complex carbohydrates during illness, stress or increased activity and before going to sleep. Limit alcohol use.
- #1 MCAD Deficiency Diagnosis and Treatmenthttps://informnetwork.org/mcad-deficiency/
Day-to-day management of this disorder consists of avoiding excessive fasting, as it could lead to a coma. How long infants should only go without food will depend on their age, but itâs typically only a few hours. Overnight fasts of 8 hours are allowed after 6 months of age. Children over one year of age can usually safely go without food for 12 to 18 hours. […] Patients appear to tolerate normal diets, but it is reasonable to modestly reduce dietary fat to < 30% of daily calories because this fuel cannot be used efficiently in MCAD deficiency. Formulas containing medium-chain triglyceride oil should be avoided. MCAD patients tend to have low blood levels of carnitine, but the use of carnitine supplementation is controversial. Some fatty acid oxidation research suggests a supplement of 50 to 100 mg/day of oral carnitine, but its usefulness is not proven.
- #1https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
The frequency of feeding for an MCADD infant, who is well, should be no different than that for a non-MCADD infant. […] Regular infant formula or breast milk can be continued in MCADD infants. […] The dietary recommendations for MCADD do not include restriction of any food group or single nutrient, so there is no a priori need for nutrient supplementation. […] A few clinics use cornstarch, Polycose or other high carbohydrate supplements/snacks as a glucose source for MCADD infants and children before the nighttime fast. […] For the individual with MCADD, intervention during illness is crucial. […] At home care for an ill MCADD individual is possible only if fasting can be avoided by providing adequate oral carbohydrate and fluid. […] The use of a concentrated oral glucose source may be lifesaving while awaiting emergency care.
- #1 Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency (MCADD) Treatment & Management: Medical Care, Consultations, Diethttps://emedicine.medscape.com/%20https://emedicine.medscape.com/article/946755-treatment
A major component of the medical treatment of medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD) deficiency is a diet that permits adequate nutrition and avoids any fasting period longer than 4-5 hours. […] Carnitine administration has been advocated on the basis of recognition of the biochemical role of carnitine in permitting conjugation and excretion of toxic intermediates. However, the evidence for any therapeutic effect is sparse and mostly anecdotal. […] A recent study provides no evidence that supplemental carnitine administration is beneficial in moderate exercise states. Moreover, patients with MCAD deficiency can replenish their stores of carnitine to compensate for carnitine losses with exercise. […] Diet should be adjusted to supply requisite nutrition for normal growth and avoid fasting periods of more than 4-5 hours in infants younger than 6 months. Thereafter, fasting of more than 8 hours should be avoided in infants aged 6-12 months, and fasting of more than 10 hours should be avoided in patients aged 12-24 months. Subsequently, no affected individual should be permitted to fast longer than 12 hours. […] Because the fundamental biochemical defect is in fatty acid oxidation, the composition of the diet should be adjusted to provide greater caloric density in carbohydrates and proteins and minimize lipids.
- #1 Medium-Chain Acyl-CoA Dehydrogenase Deficiency | Treatment & Management | Point of Carehttps://www.statpearls.com/point-of-care/24897
Some patients require bedtime doses of raw cornstarch to ensure slow glucose release overnight. […] L-carnitine supplementation of 50 to 100 mg/kg/day has historically been prescribed to patients with MCADD. This is theorized to treat secondary carnitine deficiency due to acylcarnitine accumulation. However, the benefit of this supplementation is not consistently seen in clinical trials. […] Nitrogen scavengers, eg, glycerol phenylbutyrate, are currently being studied as an adjunct therapy for patients with MCADD. […] All patients with MCADD should receive an emergency protocol letter from their metabolic specialist. This letter or a digital copy should always be kept with the patient or caregivers.
- #1 RFTS – Home Pagehttps://www.wvdhhr.org/nbms/diseases/Medium_Chain_Acyl_CoA_Dehydrogenase.asp
Treatment for MCAD deficiency consists of avoidance of fasting and mildly decreased intake of dietary fat coupled with L-carnitine supplementation. MCAD deficiency results in a secondary deficiency of carnitine, because carnitine couples with toxic intermediates, resulting in their excretion while depleting carnitine stores. Although it remains questionable how helpful supplemental carnitine is during periods when the patient with MCAD deficiency is healthy, there is no doubt that exogenous carnitine is recommended during times of illness. Another important point is that patients should be treated aggressively even during minor illnesses (eg, otitis media) to avoid a severe episode. There should be no hesitation to institute therapy with intravenous glucose and carnitine. […] Genotype/phenotype correlation is not straightforward, and the treatment of individuals with milder mutations remains controversial. There are questions yet to be answered, such as whether some (or all) individuals with the less deleterious mutations (either in combination with the common 985 mutation or in combinations with one another) who have a biochemical phenotype would ever have medical problems. In addition, would some such individuals have serious episodes and others would not because of unknown modifying factors? Until we know the answer to these and other questions, we would be remiss in not treating everyone identified, perhaps overtreating some individuals. Newborn screening for MCAD deficiency will be key in answering some of these questions.
- #1 SciELO Brazil – Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencies Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencieshttps://www.scielo.br/j/jiems/a/Qcm3gjH4smdjmkBZ6mcbcjb/?lang=en
The use of l-carnitine as adjuvant therapy is also controversial and may even aggravate the clinical condition possibly by generating toxic long-chain carnitine derivatives. […] It is expected that the development of new drugs targeting the mitochondrion, initially in animal models and thereafter as adjuvant therapeutic approaches for the patients, may become an important focus in the future. […] In this context, bezafibrate, which activates the peroxisome proliferator-activated receptor that induces transcription of various enzymes involved in mitochondrial fatty acid oxidation, was shown to normalize impaired -oxidation in skin fibroblast from patients with various FAOD, as well as improve the clinical symptoms of late-onset type glutaric acidemia type II. […] Similar effects were attributed to the antioxidant and anti-inflammatory natural compound resveratrol with positive effects on mitochondrial energy metabolism improving mitochondrial fatty acid oxidation capacities in fibroblasts from patients with VLCAD and carnitine palmitoyltransferase II deficiency. […] Thus, these compounds may represent potential novel candidates for the treatment of these diseases by a dual mechanism, improving fatty acid oxidation and counteracting oxidative stress.
- #1https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
10% dextrose, with appropriate electrolytes run at 1.5 times maintenance fluid rate, is recommended to establish and maintain normaglycemia. […] IV carnitine at a dose of 100mg/kg body weight may be needed for the short term. […] Discharge from the medical facility should not occur until the MCADD individual is able to consume sufficient oral intake to maintain normaglycemia. […] Most agree that clear liquids can be given up to 4 hours before surgery, but IV glucose should be started before the procedure and continued until the patient can consume adequate oral intake and can maintain normoglycemia. […] The individual with MCADD and/or the caregiver will: Understand importance of avoiding fasting and eating meals on a regular schedule.
- #1 MCAD Deficiency Diagnosis and Treatmenthttps://informnetwork.org/mcad-deficiency/
Medical treatment should be sought immediately if an infant or child cannot keep down formula or food, or if the child experiences loss of consciousness or severe confusion. These are all signs of dangerously low blood sugar (hypoglycemia). At the medical facility, intravenous glucose-containing fluids will be given to address the hypoglycemia. Specific therapy for the mild hyperammonemia that may be present during acute illness is not usually required, but a recent study has used an ammonia-reducing medication in MCAD deficient patients. Recovery is usually complete within 12 to 24 hours, except where serious injury to the brain has occurred. […] Currently, there are no active programs to develop additional specific treatments or management for MCAD, but new approaches may appear as products that are effective in treatment of the entire class of fatty oxidation disorders are developed. Information on current clinical trials is posted at ClinicalTrials.gov. All studies receiving U.S. government funding, as well as some supported by private industry, are posted on this government web site.
- #1 Medium Chain acyl-CoA Dehydrogenase Deficiency – Metabolic Support UKAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontResethttps://metabolicsupportuk.org/condition/medium-chain-acyl-coa-dehydrogenase-deficiency/
There is no cure for MCADD. It is a lifelong condition. However, once you know that you or your baby has the condition, it is manageable. The aim of treatment is to prevent and control the acute metabolic crisis. […] Avoid long periods without food. It is dangerous and therefore frequent intakes of food are required. However, when well, a normal infant feeding pattern, or regular healthy eating meals with a good starch intake, is all that is needed. The pattern of feeding in breast fed babies is very appropriate for an MCADD baby. […] Follow your emergency regimen â when you receive your diagnosis you will be given an emergency regimen explaining what to do if you or your child becomes ill. This includes getting bugs such as vomiting, diarrhoea and fever. Glucose polymer (energy rich drinks) are given regularly during the illness. The most common of these are Maxijul, Polycal or SOS which are all available on prescription and you will be given advice on how to use them. If you are unable to tolerate these drinks, continue to be ill and/or develop diarrhoea then you will need to be admitted to hospital to be given a glucose/dextrose drip as soon as possible. You will be given an emergency contact number to ring, however if this is unavailable call 999 for an ambulance or go to your nearest hospitalâs accident and emergency (A&E) for treatment. […] Once this disorder has been diagnosed and appropriate treatment given the prognosis is extremely good. Children will develop entirely normally and can participate in all the activities appropriate for their age.
- #1 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
Talk with your health care provider about what to do if symptoms of low blood sugar develop so that you have an emergency plan. Strategies may include: Taking simple carbohydrates, such as sugar (glucose) tablets or sweetened beverages, such as juice, that are not labeled „diet.” Seeking emergency medical care if you can’t eat or if you have diarrhea or vomiting. An intravenous (IV) line for extra glucose and additional treatment may be needed.
- #1 Acyl-coa dehydrogenase, medium-chain, deficiency of – ThinkGenetic Foundationhttps://thinkgenetic.org/diseases/acyl-coa-dehydrogenase-medium-chain-deficiency-of/
Many physicians and many emergency personnel will not be familiar with the disorder. People with MCAD deficiency should carry an emergency letter that explains MCAD deficiency and the appropriate management or treatment of a metabolic crisis. […] Women with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can have children. They need to take special precautions. […] If you are being treated for medium-chain acyl-coa dehydrogenase deficiency (MCAD), your doctor may recommend you take carnitine. […] With prompt diagnosis and treatment, children with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can avoid the symptoms associated with this disorder and experience normal development.
- #1 Exploring therapeutic approaches for treatment of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency – D-Scholarship@Pitthttp://d-scholarship.pitt.edu/21078/
Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a common biochemical genetic disorder in the US. The goal of this project was to identify chemical chaperones capable of stabilizing the K304E MCAD protein. […] Since even a small amount of MCAD activity restores metabolic flux, inducing intra-mitochondrial folding of K304E MCAD has the potential to be protective for patients. […] TMAO and glycerol significantly increased MCAD activity in these cells. […] A clinical trial testing the efficacy of phenylbutyrate in MCAD patients is underway. […] New treatments for MCADD will significantly reduce the burden of disease on these patients.
- #1 Familyhttps://patents.google.com/patent/US9283200B2/en
The present invention provides for methods and compositions in which phenylbutyrate or other source of phenylacetate is used to treat medium-chain acyl CoA dehydrogenase deficiency. […] The present invention provides for methods and compositions for treating MCADD. It is based, at least in part, on the discovery that phenylbutyrate can serve as a substrate for MCAD. In non-limiting embodiments, phenylbutyrate or another source of phenylacetate is administered as a chaperone treatment to patients suffering from MCADD. […] The present invention provides for a method of treating a subject with MCADD comprising administering, to the subject, an effective amount of phenylbutyrate, for example as a phenylbutyrate salt, as a regular therapy regimen. […] The regular therapy regimen may be administered for a duration that may be, for example, but not limited to: continuous (without a planned termination), one year, one month, two months, three months, four months, five months, six months, seven months, eight months, nine months, ten months, eleven months, one week, two weeks, three weeks, four weeks, five weeks, six weeks, seven weeks, eight weeks, nine weeks, ten weeks, eleven weeks, twelve weeks, thirteen weeks, fourteen weeks, fifteen weeks, sixteen weeks; twenty weeks; twenty eight weeks, one day, two days, three days, four days, five days, six days, seven days, eight days, nine days, ten days, eleven days, twelve days, thirteen days, fourteen days, fifteen days, sixteen days, seventeen days, eighteen days, nineteen days, twenty days, twenty-one days, twenty-two days, twenty-three days, twenty-four days, twenty-five days, twenty-six days, twenty-seven days, twenty-eight days, twenty-nine days, thirty days, or thirty-one days.
- #1 Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency | Children’s Hospital of Philadelphiahttps://www.chop.edu/conditions-diseases/medium-chain-acyl-coa-dehydrogenase-mcad-deficiency
An area that shows great promise is cell and gene therapy. […] Cell and gene therapy is an innovative and cutting-edge approach to treating certain genetic disorders like MCAD deficiency. […] Researchers at CHOP have pioneered some of the first FDA-approved cell and gene therapies for use in children. […] And we continue to investigate new ways of treating and potentially curing genetic disorders in children.
- #1https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
Before MS/MS newborn screening, nearly all cases of MCADD were diagnosed symptomatically. Intervention and treatment often addressed the serious consequences of metabolic decompensation. As more presymtomatic infants have been identified, treatments have become directed toward prevention of metabolic decompensation. […] The primary intervention goal for MCADD individuals is to avoid situations in which the cells must rely solely on stored fats for energy (i.e., avoid fasting). […] Families should be provided with an emergency protocol/letter that can be carried with them at all times. They should be strongly advised to seek medical attention if the individual with MCADD has an acute illness accompanied by poor intake, vomiting and/or lethargy. […] A concentrated glucose source should be available at all times to be used to treat hypoglycemia until emergency care can be accessed.
- #1 MCAD deficiency – Hancock Healthhttps://www.hancockhealth.org/mayo-health-library/mcad-deficiency/
Talk with your health care provider about what to do if symptoms of low blood sugar develop so that you have an emergency plan. […] Parent and family understanding of the condition is critical to ongoing care and prevention of low blood sugar episodes and other complications. […] If you or your child have MCAD deficiency, wear a medical alert bracelet or necklace and carry a medical card. […] Caring for a child or family member with a lifelong disorder such as MCAD deficiency can be challenging.
- #1 MCAD deficiency – Hancock Healthhttps://www.hancockhealth.org/mayo-health-library/mcad-deficiency/
MCAD deficiency can cause problems with your metabolism. […] Prevention and prompt treatment are essential regardless of blood sugar level. […] If MCAD deficiency is diagnosed and treated early, the disorder can be well managed through diet and lifestyle. […] A metabolic specialist, and often a registered dietitian, are usually included in your diagnosis and treatment. […] Once identified, the disorder can be managed through diet and lifestyle. […] The main goal of treatment for MCAD deficiency is to prevent problems caused by your metabolism that can lead to low blood sugar. […] Your health care team may recommend additional treatment options. […] Work with your health care team, including a registered dietitian, to develop a treatment plan tailored to your energy needs. […] Recommendations to prevent low blood sugar called hypoglycemia generally include: Avoid fasting longer than recommended by your health care team.
- #1 MCAD Deficiency: Symptoms, Treatment, Life Expectancyhttps://www.verywellhealth.com/mcad-overview-4175022
Today, testing for MCAD deficiency is part of standard newborn screenings in the United States. When diagnosed promptly, MCAD deficiency can be treated and the child can expect to live a normal life expectancy. […] The primary way to treat MCAD deficiency is to avoid prolonged fasting and ensure proper nutrition. Parents will be given strict instructions about feeding to prevent any long periods of fasting. […] In addition to having regular bottle feedings, some specialists recommend that infants be given a special formula with added simple carbohydrates (sugars, such as uncooked cornstarch) to help prevent drops in blood sugar. […] Children and adults with MCAD deficiency would also be advised to adhere to a specific diet that includes higher amounts of carbohydrates and lower amounts of fat than would typically be recommended for their age group.
- #1http://www.idph.state.il.us/healthwellness/fs/mcad.htm
Early diagnosis and treatment is essential for an improved prognosis. If left untreated, these conditions may result in significant disability and, ultimately, death. Most of these conditions are chronic, with life-long episodes of hypoglycemia. […] For most fatty acid oxidation disorders, including MCAD, management involves avoidance of fasting and aggressive medical management during illness, especially if the child is vomiting or is not receiving adequate nutritional intake. At the time of intercurrent illness, the infant/child should be admitted for medical care, including administration of intravenous dextrose to prevent hypoglycemia. Supplemental carnitine, a low-fat diet and home glucose monitoring, may be prescribed depending on the specific disorder. […] Parents should understand that treatment is lifelong and that compliance with dietary management and awareness of and prompt attention to episode triggers, including illness and fasting, are imperative to the child’s health, growth and development.
- #1http://www.idph.state.il.us/healthwellness/fs/mcad.htm
Long-term management and treatment compliance are essential to the child’s well-being. A multi-disciplinary approach including the following specialties is recommended: pediatrics, genetics and nutrition. Parents should understand that treatment is not curative; and that all morbidity cannot necessarily be prevented.
- #2 MCAD deficiency – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/symptoms-causes/syc-20353745
MCAD deficiency is present from birth and is a lifelong condition. […] If MCAD deficiency is diagnosed and treated early, the disorder can be well managed through diet and lifestyle. […] In the United States and many other countries, newborn screening programs test for MCAD deficiency. After your first evaluation, you may be referred to a specialist in evaluating and treating MCAD deficiency. You may also be referred to other health care team members, such as a registered dietitian. […] Contact your health care team if you’ve been diagnosed with MCAD deficiency and have a high fever, no appetite, stomach or digestive symptoms, or a planned medical procedure that requires fasting.
- #2 MCAD deficiency | Altru Health Systemhttps://www.altru.org/health-library/conditions/mcad-deficiency
Newborn screening at birth allows MCAD deficiency to be diagnosed and treated early, before symptoms occur, preventing complications. Once identified, the disorder can be managed through diet and lifestyle. […] The main goal of treatment for MCAD deficiency is to prevent problems caused by your metabolism that can lead to low blood sugar. To maintain blood sugar levels and avoid hypoglycemia: Infants require frequent feedings that include getting enough calories from complex carbohydrates. Children and adults need to get enough complex carbohydrates on a regular schedule of meals and snacks. […] Your health care team may recommend additional treatment options. […] Work with your health care team, including a registered dietitian, to develop a treatment plan tailored to your energy needs. This includes planning for extra complex carbohydrates needed during illness, stress or increased activity.
- #2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency | Treatment & Management | Point of Carehttps://www.statpearls.com/point-of-care/24897
MCADD has no definitive treatment; management primarily involves acute and long-term dietary interventions to prevent prolonged fasting and ensure adequate nutritional intake to meet metabolic demands during stress. […] In symptomatic patients, reversal of catabolism and treatment of hypoglycemia are the mainstay of therapy. Simple carbohydrate administration in patients who tolerate sufficient oral intake is preferred. […] Some specialists recommend a home glucose monitoring plan during acute illness or when hypoglycemic symptoms are suspected. However, subsequent management should be conducted in consultation with a metabolic specialist. […] The main goal of long-term management is to prevent prolonged fasting. […] Dietary restrictions include avoidance of foods and infant formulas that contain medium-chain fatty acids.
- #2 Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) | Revvityhttps://www.revvity.com/disorders/medium-chain-acyl-coa-dehydrogenase-deficiency-mcad
Because the diagnosis and therapy of MCAD deficiency is complex, the pediatrician is advised to manage the patient in close collaboration with a consulting pediatric metabolic disease specialist. It is recommended that parents travel with a letter of treatment guidelines from the patientâs physician.
- #2 Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency (MCADD) Treatment & Management: Medical Care, Consultations, Diethttps://emedicine.medscape.com/%20https://emedicine.medscape.com/article/946755-treatment
A major component of the medical treatment of medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD) deficiency is a diet that permits adequate nutrition and avoids any fasting period longer than 4-5 hours. […] Carnitine administration has been advocated on the basis of recognition of the biochemical role of carnitine in permitting conjugation and excretion of toxic intermediates. However, the evidence for any therapeutic effect is sparse and mostly anecdotal. […] A recent study provides no evidence that supplemental carnitine administration is beneficial in moderate exercise states. Moreover, patients with MCAD deficiency can replenish their stores of carnitine to compensate for carnitine losses with exercise. […] Diet should be adjusted to supply requisite nutrition for normal growth and avoid fasting periods of more than 4-5 hours in infants younger than 6 months. Thereafter, fasting of more than 8 hours should be avoided in infants aged 6-12 months, and fasting of more than 10 hours should be avoided in patients aged 12-24 months. Subsequently, no affected individual should be permitted to fast longer than 12 hours. […] Because the fundamental biochemical defect is in fatty acid oxidation, the composition of the diet should be adjusted to provide greater caloric density in carbohydrates and proteins and minimize lipids.
- #2 MCAD Deficiency Diagnosis and Treatmenthttps://informnetwork.org/mcad-deficiency/
Day-to-day management of this disorder consists of avoiding excessive fasting, as it could lead to a coma. How long infants should only go without food will depend on their age, but itâs typically only a few hours. Overnight fasts of 8 hours are allowed after 6 months of age. Children over one year of age can usually safely go without food for 12 to 18 hours. […] Patients appear to tolerate normal diets, but it is reasonable to modestly reduce dietary fat to < 30% of daily calories because this fuel cannot be used efficiently in MCAD deficiency. Formulas containing medium-chain triglyceride oil should be avoided. MCAD patients tend to have low blood levels of carnitine, but the use of carnitine supplementation is controversial. Some fatty acid oxidation research suggests a supplement of 50 to 100 mg/day of oral carnitine, but its usefulness is not proven.
- #2 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
MCAD deficiency is diagnosed through newborn screening followed by genetic testing. […] A metabolic specialist, and often a registered dietitian, are usually included in your diagnosis and treatment. Lab tests can be done to help identify problems with your metabolism the processes your body uses to produce energy. Results can help treat or prevent complications. […] Newborn screening at birth allows MCAD deficiency to be diagnosed and treated early, before symptoms occur, preventing complications. Once identified, the disorder can be managed through diet and lifestyle. […] The main goal of treatment for MCAD deficiency is to prevent problems caused by your metabolism that can lead to low blood sugar. To maintain blood sugar levels and avoid hypoglycemia: Infants require frequent feedings that include getting enough calories from complex carbohydrates. Children and adults need to get enough complex carbohydrates on a regular schedule of meals and snacks.
- #2 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency – GeneReviews® – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK1424/
Management. Treatment of manifestations: For routine daily treatment, fasting should be avoided and may require frequent feeding (every 2-3 hours) in infancy, overnight feeding, a bedtime snack, or 2 g/kg of uncooked cornstarch to maintain blood glucose levels during sleep. A normal, healthy diet containing no more than 30% of total energy from fat is recommended. All individuals with MCAD deficiency should avoid skipping meals and weight loss diets that recommend fasting. Prolonged or intense exercise should be covered by adequate carbohydrate intake and hydration. Intravenous glucose is recommended for surgical procedures that require several hours of fasting. Weight control measures such as regular education about proper nutrition and recommended physical exercise should be discussed to help avoid obesity. Standard treatment for developmental delay / aphasia, attention-deficit/hyperactivity disorder, and muscle weakness. For acute inpatient treatment, IV administration of glucose should be initiated immediately with 10% dextrose with appropriate electrolytes at a rate of 1.5 times maintenance rate or at 10-12 mg glucose/kg/minute to achieve and maintain a blood glucose level higher than 5 mmol/L, or between 120 and 170 mg/dL. Address electrolyte and pH imbalances with intravenous fluid management and initiate appropriate treatment for what triggered the metabolic stress.
- #2 MCAD deficiency | Altru Health Systemhttps://www.altru.org/health-library/conditions/mcad-deficiency
Recommendations to prevent low blood sugar called hypoglycemia generally include: Avoid fasting longer than recommended by your health care team. Eat regular meals and snacks with adequate calories from complex carbohydrates, such as brown bread, rice, pasta and cereal, for energy needs. Choose foods that are high in complex carbohydrates and lower in fat. Increase calories by eating extra complex carbohydrates during illness, stress or increased activity and before going to sleep. Limit alcohol use. […] Talk with your health care provider about what to do if symptoms of low blood sugar develop so that you have an emergency plan. Strategies may include: Taking simple carbohydrates, such as sugar (glucose) tablets or sweetened beverages, such as juice, that are not labeled „diet.” Seeking emergency medical care if you can’t eat or if you have diarrhea or vomiting. An intravenous (IV) line for extra glucose and additional treatment may be needed.
- #2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency | Treatment & Management | Point of Carehttps://www.statpearls.com/point-of-care/24897
Some patients require bedtime doses of raw cornstarch to ensure slow glucose release overnight. […] L-carnitine supplementation of 50 to 100 mg/kg/day has historically been prescribed to patients with MCADD. This is theorized to treat secondary carnitine deficiency due to acylcarnitine accumulation. However, the benefit of this supplementation is not consistently seen in clinical trials. […] Nitrogen scavengers, eg, glycerol phenylbutyrate, are currently being studied as an adjunct therapy for patients with MCADD. […] All patients with MCADD should receive an emergency protocol letter from their metabolic specialist. This letter or a digital copy should always be kept with the patient or caregivers.
- #2 RFTS – Home Pagehttps://www.wvdhhr.org/nbms/diseases/Medium_Chain_Acyl_CoA_Dehydrogenase.asp
Treatment for MCAD deficiency consists of avoidance of fasting and mildly decreased intake of dietary fat coupled with L-carnitine supplementation. MCAD deficiency results in a secondary deficiency of carnitine, because carnitine couples with toxic intermediates, resulting in their excretion while depleting carnitine stores. Although it remains questionable how helpful supplemental carnitine is during periods when the patient with MCAD deficiency is healthy, there is no doubt that exogenous carnitine is recommended during times of illness. Another important point is that patients should be treated aggressively even during minor illnesses (eg, otitis media) to avoid a severe episode. There should be no hesitation to institute therapy with intravenous glucose and carnitine. […] Genotype/phenotype correlation is not straightforward, and the treatment of individuals with milder mutations remains controversial. There are questions yet to be answered, such as whether some (or all) individuals with the less deleterious mutations (either in combination with the common 985 mutation or in combinations with one another) who have a biochemical phenotype would ever have medical problems. In addition, would some such individuals have serious episodes and others would not because of unknown modifying factors? Until we know the answer to these and other questions, we would be remiss in not treating everyone identified, perhaps overtreating some individuals. Newborn screening for MCAD deficiency will be key in answering some of these questions.
- #2https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
The frequency of feeding for an MCADD infant, who is well, should be no different than that for a non-MCADD infant. […] Regular infant formula or breast milk can be continued in MCADD infants. […] The dietary recommendations for MCADD do not include restriction of any food group or single nutrient, so there is no a priori need for nutrient supplementation. […] A few clinics use cornstarch, Polycose or other high carbohydrate supplements/snacks as a glucose source for MCADD infants and children before the nighttime fast. […] For the individual with MCADD, intervention during illness is crucial. […] At home care for an ill MCADD individual is possible only if fasting can be avoided by providing adequate oral carbohydrate and fluid. […] The use of a concentrated oral glucose source may be lifesaving while awaiting emergency care.
- #2 Medium Chain acyl-CoA Dehydrogenase Deficiency – Metabolic Support UKAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontResethttps://metabolicsupportuk.org/condition/medium-chain-acyl-coa-dehydrogenase-deficiency/
There is no cure for MCADD. It is a lifelong condition. However, once you know that you or your baby has the condition, it is manageable. The aim of treatment is to prevent and control the acute metabolic crisis. […] Avoid long periods without food. It is dangerous and therefore frequent intakes of food are required. However, when well, a normal infant feeding pattern, or regular healthy eating meals with a good starch intake, is all that is needed. The pattern of feeding in breast fed babies is very appropriate for an MCADD baby. […] Follow your emergency regimen â when you receive your diagnosis you will be given an emergency regimen explaining what to do if you or your child becomes ill. This includes getting bugs such as vomiting, diarrhoea and fever. Glucose polymer (energy rich drinks) are given regularly during the illness. The most common of these are Maxijul, Polycal or SOS which are all available on prescription and you will be given advice on how to use them. If you are unable to tolerate these drinks, continue to be ill and/or develop diarrhoea then you will need to be admitted to hospital to be given a glucose/dextrose drip as soon as possible. You will be given an emergency contact number to ring, however if this is unavailable call 999 for an ambulance or go to your nearest hospitalâs accident and emergency (A&E) for treatment. […] Once this disorder has been diagnosed and appropriate treatment given the prognosis is extremely good. Children will develop entirely normally and can participate in all the activities appropriate for their age.
- #2 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
Talk with your health care provider about what to do if symptoms of low blood sugar develop so that you have an emergency plan. Strategies may include: Taking simple carbohydrates, such as sugar (glucose) tablets or sweetened beverages, such as juice, that are not labeled „diet.” Seeking emergency medical care if you can’t eat or if you have diarrhea or vomiting. An intravenous (IV) line for extra glucose and additional treatment may be needed.
- #2https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
10% dextrose, with appropriate electrolytes run at 1.5 times maintenance fluid rate, is recommended to establish and maintain normaglycemia. […] IV carnitine at a dose of 100mg/kg body weight may be needed for the short term. […] Discharge from the medical facility should not occur until the MCADD individual is able to consume sufficient oral intake to maintain normaglycemia. […] Most agree that clear liquids can be given up to 4 hours before surgery, but IV glucose should be started before the procedure and continued until the patient can consume adequate oral intake and can maintain normoglycemia. […] The individual with MCADD and/or the caregiver will: Understand importance of avoiding fasting and eating meals on a regular schedule.
- #2 MCAD Deficiency Diagnosis and Treatmenthttps://informnetwork.org/mcad-deficiency/
Medical treatment should be sought immediately if an infant or child cannot keep down formula or food, or if the child experiences loss of consciousness or severe confusion. These are all signs of dangerously low blood sugar (hypoglycemia). At the medical facility, intravenous glucose-containing fluids will be given to address the hypoglycemia. Specific therapy for the mild hyperammonemia that may be present during acute illness is not usually required, but a recent study has used an ammonia-reducing medication in MCAD deficient patients. Recovery is usually complete within 12 to 24 hours, except where serious injury to the brain has occurred. […] Currently, there are no active programs to develop additional specific treatments or management for MCAD, but new approaches may appear as products that are effective in treatment of the entire class of fatty oxidation disorders are developed. Information on current clinical trials is posted at ClinicalTrials.gov. All studies receiving U.S. government funding, as well as some supported by private industry, are posted on this government web site.
- #2 MCAD deficiency – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/mcad-deficiency/diagnosis-treatment/drc-20353747
Your health care team may recommend additional treatment options. […] Work with your health care team, including a registered dietitian, to develop a treatment plan tailored to your energy needs. This includes planning for extra complex carbohydrates needed during illness, stress or increased activity. […] Recommendations to prevent low blood sugar called hypoglycemia generally include: Avoid fasting longer than recommended by your health care team. Eat regular meals and snacks with adequate calories from complex carbohydrates, such as brown bread, rice, pasta and cereal, for energy needs. Choose foods that are high in complex carbohydrates and lower in fat. Increase calories by eating extra complex carbohydrates during illness, stress or increased activity and before going to sleep. Limit alcohol use.
- #2 Use of Ravicti⢠in Patients With MCAD Deficiency With the 985A>G (K304E) Mutationhttps://ctv.veeva.com/study/use-of-ravicti-in-patients-with-mcad-deficiency-with-the-985a-g-k304e-mutation
This is a medical research study to test a medication in adult patients with a disease called medium-chain acyl-CoA dehydrogenase (MCAD) deficiency caused by at least one copy of the 985AG mutation. The medication is glycerol phenylbutyrate, called Ravicti, which is currently FDA approved for the treatment of urea cycle disorders. Previous research suggests that Ravicti may also be effective in the treatment MCAD deficiency. This study will investigate the safety and efficacy (how well it works) of Ravicti in patients with MCAD deficiency caused by having at least one copy of the 985AG mutation. […] Dosing for this study will begin at 2 grams/m2/day, which is about one-fifth (1/5) the dose used for other disorders. The reason for starting the dose lower in MCAD patients is that Ravicti is metabolized by the MCAD enzyme.
- #2 Acyl-coa dehydrogenase, medium-chain, deficiency of – ThinkGenetic Foundationhttps://thinkgenetic.org/diseases/acyl-coa-dehydrogenase-medium-chain-deficiency-of/
Many physicians and many emergency personnel will not be familiar with the disorder. People with MCAD deficiency should carry an emergency letter that explains MCAD deficiency and the appropriate management or treatment of a metabolic crisis. […] Women with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can have children. They need to take special precautions. […] If you are being treated for medium-chain acyl-coa dehydrogenase deficiency (MCAD), your doctor may recommend you take carnitine. […] With prompt diagnosis and treatment, children with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can avoid the symptoms associated with this disorder and experience normal development.
- #2 MCAD Deficiency: Symptoms, Causes and Treatmenthttps://www.medicoverhospitals.in/diseases/mcad-deficiency/
Effective management of MCAD deficiency focuses on preventing metabolic crises through dietary modifications and regular monitoring. […] Treatment usually includes dietary management to avoid fasting, with emergency measures to manage hypoglycemic episodes. […] Frequent Meals: Regular, balanced meals rich in carbohydrates can help maintain stable blood sugar levels and prevent hypoglycemia. […] Avoidance of Fasting: Ensuring frequent food intake, especially during illness or stress, is crucial to prevent metabolic decompensation. […] Medium-Chain Triglycerides (MCTs): Some individuals may benefit from supplements containing medium-chain triglycerides, which can be metabolized more easily than long-chain fatty acids. […] During illness or periods of stress, individuals with MCAD deficiency may require hospitalization and intravenous glucose to prevent hypoglycemia and metabolic crises. Prompt medical attention is vital to prevent serious complications. […] Ongoing management of MCAD deficiency involves regular follow-ups with healthcare providers to monitor growth, development, and metabolic control. This proactive approach helps prevent complications and ensures optimal health outcomes.
- #2http://www.idph.state.il.us/healthwellness/fs/mcad.htm
Early diagnosis and treatment is essential for an improved prognosis. If left untreated, these conditions may result in significant disability and, ultimately, death. Most of these conditions are chronic, with life-long episodes of hypoglycemia. […] For most fatty acid oxidation disorders, including MCAD, management involves avoidance of fasting and aggressive medical management during illness, especially if the child is vomiting or is not receiving adequate nutritional intake. At the time of intercurrent illness, the infant/child should be admitted for medical care, including administration of intravenous dextrose to prevent hypoglycemia. Supplemental carnitine, a low-fat diet and home glucose monitoring, may be prescribed depending on the specific disorder. […] Parents should understand that treatment is lifelong and that compliance with dietary management and awareness of and prompt attention to episode triggers, including illness and fasting, are imperative to the child’s health, growth and development.
- #2 Medium-chain acyl-CoA dehydrogenase deficiency | Myriad Foresight® Carrier Screenhttps://myriad.com/womens-health/diseases/medium-chain-acyl-coa-dehydrogenase-deficiency/
The key treatment for individuals with MCAD deficiency is to avoid fasting. Infants must be frequently fed a formula low in fat but high in carbohydrates. For children and adults, consuming cornstarch can also provide a sustained release of energy and allow for longer gaps between meals. If an individual is unable to eat or drink food on their own, it may be necessary to give them glucose by intravenous fluids. […] Early diagnosis and dietary management are crucial for the best outcome. If dietary management starts early (especially before the onset of symptoms) and is consistent, individuals with MCAD deficiency have a good prognosis with normal or near-normal lifespan. In undiagnosed and untreated cases of MCAD deficiency, symptoms can quickly cause irreversible damage or even lead to death.
- #2 MCAD Deficiency: Symptoms, Treatment, Life Expectancyhttps://www.verywellhealth.com/mcad-overview-4175022
In addition to ensuring appropriate nutrition, strict adherence to a regular feeding schedule will need to begin from the time of diagnosis. […] If a person with MCAD deficiency becomes ill and cannot eat, they may need to receive nutrition and fluids through an IV drip or feeding tube at the hospital to prevent complications. […] If MCAD deficiency is properly managed, a person can live a long and healthy life. However, if left undiagnosed and untreated, the risk of death is estimated to be around 20%. Most deaths occur during early childhood. […] People with MCAD deficiency usually need to adhere to a diet that is high in carbohydrates and low in fat. They also need to avoid long periods of fasting. If properly managed, most people with MCAD deficiency can lead normal, healthy lives.
- #2http://www.idph.state.il.us/healthwellness/fs/mcad.htm
Long-term management and treatment compliance are essential to the child’s well-being. A multi-disciplinary approach including the following specialties is recommended: pediatrics, genetics and nutrition. Parents should understand that treatment is not curative; and that all morbidity cannot necessarily be prevented.
- #3 MCAD Deficiency: Symptoms, Treatment, Life Expectancyhttps://www.verywellhealth.com/mcad-overview-4175022
Today, testing for MCAD deficiency is part of standard newborn screenings in the United States. When diagnosed promptly, MCAD deficiency can be treated and the child can expect to live a normal life expectancy. […] The primary way to treat MCAD deficiency is to avoid prolonged fasting and ensure proper nutrition. Parents will be given strict instructions about feeding to prevent any long periods of fasting. […] In addition to having regular bottle feedings, some specialists recommend that infants be given a special formula with added simple carbohydrates (sugars, such as uncooked cornstarch) to help prevent drops in blood sugar. […] Children and adults with MCAD deficiency would also be advised to adhere to a specific diet that includes higher amounts of carbohydrates and lower amounts of fat than would typically be recommended for their age group.
- #3 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency – GeneReviews® – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK1424/
There is no cure for MCAD deficiency. However, routine dietary therapy can ameliorate and/or prevent symptoms of this condition. […] Avoidance of fasting remains the cornerstone of MCAD deficiency treatment. Although management of any given affected individual is nuanced and managed on a case-by-case basis, minor illnesses, where caloric needs are increased or provision of adequate calories is compromised, should be observed closely and promptly treated with a low threshold for hospital admission. An emergency management protocol should be in place and parents or caregivers should be given an emergency letter.
- #3 Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency (MCADD) Treatment & Management: Medical Care, Consultations, Diethttps://emedicine.medscape.com/%20https://emedicine.medscape.com/article/946755-treatment
A major component of the medical treatment of medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD) deficiency is a diet that permits adequate nutrition and avoids any fasting period longer than 4-5 hours. […] Carnitine administration has been advocated on the basis of recognition of the biochemical role of carnitine in permitting conjugation and excretion of toxic intermediates. However, the evidence for any therapeutic effect is sparse and mostly anecdotal. […] A recent study provides no evidence that supplemental carnitine administration is beneficial in moderate exercise states. Moreover, patients with MCAD deficiency can replenish their stores of carnitine to compensate for carnitine losses with exercise. […] Diet should be adjusted to supply requisite nutrition for normal growth and avoid fasting periods of more than 4-5 hours in infants younger than 6 months. Thereafter, fasting of more than 8 hours should be avoided in infants aged 6-12 months, and fasting of more than 10 hours should be avoided in patients aged 12-24 months. Subsequently, no affected individual should be permitted to fast longer than 12 hours. […] Because the fundamental biochemical defect is in fatty acid oxidation, the composition of the diet should be adjusted to provide greater caloric density in carbohydrates and proteins and minimize lipids.
- #3 Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) | Revvityhttps://www.revvity.com/disorders/medium-chain-acyl-coa-dehydrogenase-deficiency-mcad
Fundamental to the medical management of MCAD is the need to avoid fasting, particularly during periods of high metabolic stress, such as illness. Overnight fasts should be managed with nighttime or late evening feedings where appropriate. The addition of food-grade cornstarch mixed in liquid at bedtime has also helped to decrease the frequency of morning hypoglycemia in some patients. High carbohydrate intake should be encouraged during illnesses, with initiation of intravenous glucose supplementation if the child is unsuccessful in keeping down fluids or unable to take adequate oral feedings. […] Supplementation with oral L-carnitine has been associated with a reduction in the frequency and severity of episodes. The continued need for carnitine supplementation post-puberty is uncertain, and has not been adequately studied.
- #3 SciELO Brazil – Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencies Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencieshttps://www.scielo.br/j/jiems/a/Qcm3gjH4smdjmkBZ6mcbcjb/?lang=en
The use of l-carnitine as adjuvant therapy is also controversial and may even aggravate the clinical condition possibly by generating toxic long-chain carnitine derivatives. […] It is expected that the development of new drugs targeting the mitochondrion, initially in animal models and thereafter as adjuvant therapeutic approaches for the patients, may become an important focus in the future. […] In this context, bezafibrate, which activates the peroxisome proliferator-activated receptor that induces transcription of various enzymes involved in mitochondrial fatty acid oxidation, was shown to normalize impaired -oxidation in skin fibroblast from patients with various FAOD, as well as improve the clinical symptoms of late-onset type glutaric acidemia type II. […] Similar effects were attributed to the antioxidant and anti-inflammatory natural compound resveratrol with positive effects on mitochondrial energy metabolism improving mitochondrial fatty acid oxidation capacities in fibroblasts from patients with VLCAD and carnitine palmitoyltransferase II deficiency. […] Thus, these compounds may represent potential novel candidates for the treatment of these diseases by a dual mechanism, improving fatty acid oxidation and counteracting oxidative stress.
- #3https://gmdi.org/Resources/Nutrition-Guidelines/MCAD
The frequency of feeding for an MCADD infant, who is well, should be no different than that for a non-MCADD infant. […] Regular infant formula or breast milk can be continued in MCADD infants. […] The dietary recommendations for MCADD do not include restriction of any food group or single nutrient, so there is no a priori need for nutrient supplementation. […] A few clinics use cornstarch, Polycose or other high carbohydrate supplements/snacks as a glucose source for MCADD infants and children before the nighttime fast. […] For the individual with MCADD, intervention during illness is crucial. […] At home care for an ill MCADD individual is possible only if fasting can be avoided by providing adequate oral carbohydrate and fluid. […] The use of a concentrated oral glucose source may be lifesaving while awaiting emergency care.
- #3 MCAD deficiency | Altru Health Systemhttps://www.altru.org/health-library/conditions/mcad-deficiency
Recommendations to prevent low blood sugar called hypoglycemia generally include: Avoid fasting longer than recommended by your health care team. Eat regular meals and snacks with adequate calories from complex carbohydrates, such as brown bread, rice, pasta and cereal, for energy needs. Choose foods that are high in complex carbohydrates and lower in fat. Increase calories by eating extra complex carbohydrates during illness, stress or increased activity and before going to sleep. Limit alcohol use. […] Talk with your health care provider about what to do if symptoms of low blood sugar develop so that you have an emergency plan. Strategies may include: Taking simple carbohydrates, such as sugar (glucose) tablets or sweetened beverages, such as juice, that are not labeled „diet.” Seeking emergency medical care if you can’t eat or if you have diarrhea or vomiting. An intravenous (IV) line for extra glucose and additional treatment may be needed.
- #3 Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) — New England Consortium of Metabolic Programshttps://www.newenglandconsortium.org/mcadd
These acute illness materials are a guideline for healthcare professionals treating the sick infant/child who has previously been diagnosed with medium chain acyl-CoA dehydrogenase deficiency (MCADD), a fatty acid oxidation disorder (FAOD). […] Metabolic crises in infants/children with FAOD are medical emergencies and must be treated as such to avoid death or serious brain injury. […] These materials are only a guideline and should not be used for definitive treatment without metabolic consultation. […] Immediate attention and therapy is the key to preventing sudden death. […] Treatment: 1. INDICATION FOR IV (NEVER less than 10% dextrose IV infusion) (One or more indication is sufficient for IV) […] 2. HYPOGLYCEMIA […] push 25% dextrose 2ml/kg and follow with a continuous 10% dextrose infusion at 1.5x maintenance, to provide 7-8 mg/kg/min glucose.
- #3 Acyl-coa dehydrogenase, medium-chain, deficiency of – ThinkGenetic Foundationhttps://thinkgenetic.org/diseases/acyl-coa-dehydrogenase-medium-chain-deficiency-of/
Many physicians and many emergency personnel will not be familiar with the disorder. People with MCAD deficiency should carry an emergency letter that explains MCAD deficiency and the appropriate management or treatment of a metabolic crisis. […] Women with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can have children. They need to take special precautions. […] If you are being treated for medium-chain acyl-coa dehydrogenase deficiency (MCAD), your doctor may recommend you take carnitine. […] With prompt diagnosis and treatment, children with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency can avoid the symptoms associated with this disorder and experience normal development.
- #3 Medium Chain acyl-CoA Dehydrogenase Deficiency – Metabolic Support UKAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontResethttps://metabolicsupportuk.org/condition/medium-chain-acyl-coa-dehydrogenase-deficiency/
There is no cure for MCADD. It is a lifelong condition. However, once you know that you or your baby has the condition, it is manageable. The aim of treatment is to prevent and control the acute metabolic crisis. […] Avoid long periods without food. It is dangerous and therefore frequent intakes of food are required. However, when well, a normal infant feeding pattern, or regular healthy eating meals with a good starch intake, is all that is needed. The pattern of feeding in breast fed babies is very appropriate for an MCADD baby. […] Follow your emergency regimen â when you receive your diagnosis you will be given an emergency regimen explaining what to do if you or your child becomes ill. This includes getting bugs such as vomiting, diarrhoea and fever. Glucose polymer (energy rich drinks) are given regularly during the illness. The most common of these are Maxijul, Polycal or SOS which are all available on prescription and you will be given advice on how to use them. If you are unable to tolerate these drinks, continue to be ill and/or develop diarrhoea then you will need to be admitted to hospital to be given a glucose/dextrose drip as soon as possible. You will be given an emergency contact number to ring, however if this is unavailable call 999 for an ambulance or go to your nearest hospitalâs accident and emergency (A&E) for treatment. […] Once this disorder has been diagnosed and appropriate treatment given the prognosis is extremely good. Children will develop entirely normally and can participate in all the activities appropriate for their age.
- #3 Medium-chain acyl-CoA dehydrogenase deficiency | Myriad Foresight® Carrier Screenhttps://myriad.com/womens-health/diseases/medium-chain-acyl-coa-dehydrogenase-deficiency/
The key treatment for individuals with MCAD deficiency is to avoid fasting. Infants must be frequently fed a formula low in fat but high in carbohydrates. For children and adults, consuming cornstarch can also provide a sustained release of energy and allow for longer gaps between meals. If an individual is unable to eat or drink food on their own, it may be necessary to give them glucose by intravenous fluids. […] Early diagnosis and dietary management are crucial for the best outcome. If dietary management starts early (especially before the onset of symptoms) and is consistent, individuals with MCAD deficiency have a good prognosis with normal or near-normal lifespan. In undiagnosed and untreated cases of MCAD deficiency, symptoms can quickly cause irreversible damage or even lead to death.
- #4 Medium Chain acyl-CoA Dehydrogenase Deficiency – Metabolic Support UKAccessibility ToolsIncrease TextDecrease TextGrayscaleHigh ContrastNegative ContrastLight BackgroundLinks UnderlineReadable FontResethttps://metabolicsupportuk.org/condition/medium-chain-acyl-coa-dehydrogenase-deficiency/
There is no cure for MCADD. It is a lifelong condition. However, once you know that you or your baby has the condition, it is manageable. The aim of treatment is to prevent and control the acute metabolic crisis. […] Avoid long periods without food. It is dangerous and therefore frequent intakes of food are required. However, when well, a normal infant feeding pattern, or regular healthy eating meals with a good starch intake, is all that is needed. The pattern of feeding in breast fed babies is very appropriate for an MCADD baby. […] Follow your emergency regimen â when you receive your diagnosis you will be given an emergency regimen explaining what to do if you or your child becomes ill. This includes getting bugs such as vomiting, diarrhoea and fever. Glucose polymer (energy rich drinks) are given regularly during the illness. The most common of these are Maxijul, Polycal or SOS which are all available on prescription and you will be given advice on how to use them. If you are unable to tolerate these drinks, continue to be ill and/or develop diarrhoea then you will need to be admitted to hospital to be given a glucose/dextrose drip as soon as possible. You will be given an emergency contact number to ring, however if this is unavailable call 999 for an ambulance or go to your nearest hospitalâs accident and emergency (A&E) for treatment. […] Once this disorder has been diagnosed and appropriate treatment given the prognosis is extremely good. Children will develop entirely normally and can participate in all the activities appropriate for their age.